Brainstorm Cell Therapeutics

Chaim Lebovits, CEO
New York City, NY
(NASDAQ: BCLI)

Virtual Presentation

BrainStorm Cell Therapeutics is a clinical-stage, publicly-traded, biotechnology company focused on the development of best-in-class autologous cellular therapeutics for the treatment of highly debilitating neurodegenerative diseases.
www.brainstorm-cell.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions